For mesothelioma patients, studies and trials may offer access to promising treatments not yet available to the public. But for those pursuing legal claims related to asbestos exposure, the decision to join a clinical trial can raise important questions.
Will it affect your eligibility for compensation? Could it complicate the legal process? Before making your decision, learn more about the potential impact of trial participation.
Clinical trials and legal eligibility
Participating in a clinical trial does not disqualify someone from filing a legal claim. Most mesothelioma lawsuits focus on proving asbestos exposure and identifying responsible parties.
Treatment choices, whether standard or experimental, typically do not alter the core facts of the case. However, some defendants may attempt to argue that trial participation complicates causation or damages, so it’s important to be prepared.
Impact on compensation amounts
Joining a clinical trial may influence how damages are calculated, especially if the treatment leads to improved outcomes. Defendants might argue that experimental therapies reduce the need for certain types of compensation, such as future medical costs or pain and suffering.
On the other hand, trial participation can also demonstrate a patient’s proactive approach to care, which some courts may view favorably.
Timing and documentation considerations
Clinical trials often involve extensive paperwork, medical evaluations and travel. These factors can affect the timing of a legal claim or settlement. It’s crucial to keep detailed records and communicate with both your legal team and medical providers to avoid delays or misunderstandings.
Before enrolling in any clinical trial, mesothelioma patients should seek a qualified legal opinion from someone who understands asbestos litigation. Legal guidance can help ensure all the decisions you make strengthen rather than weaken your position.